In this second of two, interactive CMEO BriefCase demonstrations, an expert faculty will react to the actions taken by a clinician when her patient becomes pregnant while taking mycophenolate three years post-kidney transplantation. The program will emphasize pros and cons about the clinician-patient interactions highlighted in the vignettes, while offering practical information on the steps involved for both patients and clinicians to participate in the Mycophenolate Pregnancy Registry.
In this first installment of a two-part interactive CMEO BriefCase demonstration, expert clinicians in transplantation, immunosuppression, and patient care react to video case vignettes that include counseling on contraception. The faculty provides perspectives on interactions done well and offers advice on how they can be improved to ensure successful pregnancy prevention during mycophenolate administration.
Given the recent position statement from the American Headache Society endorsing calcitonin gene-related peptide receptor antagonists (CGRP-RAs) for first-line prevention of migraine, it is crucial for primary care practitioners to ensure all patients have access to the latest, evidence-based treatments. In this activity, expert faculty will address the educational needs of non-migraine specialist healthcare practitioners. We will discuss common challenges faced by the multidisciplinary care team, including shared decision-making practices to determine the best treatment options for patients.
In this activity, expert faculty will guide you through the evaluation of a patient in the ED, followed by discussions on treatment options, referral processes, accurate diagnosis, and subsequent visits with a neurologist. We will address the educational needs of emergency medicine, non-migraine specialist practitioners and discuss common challenges faced by the multidisciplinary care team to determine the best treatment options for patients.
In this CME Outfitters BriefCase, part of a collection on health equity, expert faculty will discuss actionable strategies to enhance health equity in the treatment of ABCD. The focus will be on identifying and mitigating the impact of social drivers of health (SDoH), integrating holistic and culturally congruent care strategies, and employing team-based approaches to ensure equitable treatment outcomes. Learners will gain tools to improve diagnosis, intervention, and long-term care for patients with ABCD, particularly those from high-risk, underserved populations.
In this CME Outfitters BriefCase, part of a collection on health equity, expert faculty will explore strategies to enhance mental health care for underserved populations. Focus will be placed on understanding and mitigating the impact of social drivers of health (SDoH), integrating holistic treatment strategies, and employing team-based approaches. Learners will gain tools to improve diagnosis, treatment, and outcomes for racial, ethnic, and LGBTQIA+ groups, fostering equitable mental health care delivery.
Rakesh Jain, MD, MPH, is a Clinical Professor in the department of Psychiatry at the Texas Tech Health Sciences Center School of Medicine – Permian Basin in Midland, Texas and in private practice in Austin, Texas. Dr. Jain attended medical school at the University of Calcutta in India. He received his Master of Public Health (MPH) degree from the University of Texas School of Public Health in Houston, where he was awarded a National Institute/Center for Disease Control Competitive Traineeship. His research thesis focused on the impact of substance abuse.
Dr. Jain completed his residency in psychiatry at the Department of Psychiatry and Behavioral Sciences at the University of Texas Medical School at Houston. He then completed a postdoctoral fellowship in research psychiatry at the University of Texas Mental Sciences Institute in Houston. He was awarded the National Research Service Award in support of his postdoctoral fellowship.
Dr. Jain has been involved in over 100 research projects studying the effects of medications on short-term and long-term treatment of depression, anxiety, pain/mood overlap disorders, ADHD, and psychosis in adult and child/adolescent populations. He has presented at the World Psychiatric Congress held in Prague, and at Depression and Pain Forum meetings internationally. He is the author of 55 articles published in various journals and magazines, such as the Journal of Psychiatric Research and Journal of Clinical Psychiatry, among others, and has presented over 25 original research posters at meetings such as the American Psychological Association (APA), the American College of Neuropsychopharmacology (ACNP), the American Academy of Child and Adolescent Psychiatry (AACAP), the U.S. Psychiatric Congress, and more. He has co-authored six books that range from patient education to cutting-edge neurobiologic findings in psychiatry and mental health. He serves on several advisory boards focusing on drug development and disease state education. He was also recently the Chair of the U.S. Psychiatric Congress, and for several years, has served as a member of the Steering Committee for U.S. Psychiatric Annual Congress. He is a recipient of the Public Citizen of the Year award from the National Association of Social Workers, Gulf Coast Chapter, in recognition of his community and peer education, and championing of mental health issues.